Table 4 Imaging and medications os patients regarding access to care, by referral status
|  | Referred (N = 70) | Not Referred (N = 79) | P-value |
|---|---|---|---|
Number of patients with additional cardiac imaging | |||
 MUGA scan | 7 | 16 | p = 0.11 |
 Cardiac CT/MRI | 4 | 2 | p = 0.42 |
 Stress test | 11 | 7 | p = 0.22 |
 RHC | 2 | 4 | p = 0.68 |
 LHC | 1 | 7 | p = 0.07 |
Medication post-chemo | |||
 Beta blocker | 54 | 24 | p < 0.0001 |
 ACEI/ARB | 50 | 26 | p < 0.0001 |
 Diuretic | 22 | 18 | p = 0.23 |
 CCB | 14 | 18 | p = 0.68 |
 Hydralazine | 6 | 1 | p = 0.035 |
 Nitrate | 4 | 1 | p = 0.13 |
 MRA | 7 | 1 | p = 0.018 |
 Antiarrhythmic | 2 | 0 | p = 0.49 |
 Aspirin | 24 | 20 | p = 0.23 |
 Statin | 32 | 22 | p = 0.024 |